Dr Nordvall is Principal Scientist in Medicinal Chemistry, where he oversaw and guided medicinal chemistry programs in the neurology and pain portfolio. He has contributed to more than 20 projects and been part of numerous scientific review committees. He has extensive knowledge and experience in both medicinal- and computational chemistry and is an expert in drug design. Dr Nordvall has served as project leader, medicinal chemistry project leader as well as manager for lead generation computational chemistry. He has more than 15 years experience in working with project generation and target evaluation, in particular for Alzheimer’s disease but also for other CNS disorders. In his background, he has a Master of Pharmaceutical Sciences degree and he received a PhD in Medicinal Chemistry from Uppsala University at the Department of Organic Pharmaceutical Chemistry.
Research interest on Medicinal and Computational Chemistry